
Carmencita Belei
Examiner (ID: 5021, Phone: (571)272-2798 , Office: P/1678 )
| Most Active Art Unit | 1678 |
| Art Unit(s) | 1677, 1641, 1678 |
| Total Applications | 403 |
| Issued Applications | 162 |
| Pending Applications | 10 |
| Abandoned Applications | 231 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11944463
[patent_doc_number] => 20170248615
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-31
[patent_title] => 'METHODS FOR EVALUATING RENAL INJURY AND RENAL FAILURE USING URINE LEVELS OF CHITINASE-3-LIKE PROTEIN 1'
[patent_app_type] => utility
[patent_app_number] => 15/595691
[patent_app_country] => US
[patent_app_date] => 2017-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24481
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15595691
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/595691 | METHODS FOR EVALUATING RENAL INJURY AND RENAL FAILURE USING URINE LEVELS OF CHITINASE-3-LIKE PROTEIN 1 | May 14, 2017 | Abandoned |
Array
(
[id] => 11995451
[patent_doc_number] => 20170299606
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-19
[patent_title] => 'IMMUNO-MALDI TO MEASURE AKT1 AND AKT2 PHOSPHORYLATION'
[patent_app_type] => utility
[patent_app_number] => 15/489485
[patent_app_country] => US
[patent_app_date] => 2017-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 23218
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15489485
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/489485 | IMMUNO-MALDI TO MEASURE AKT1 AND AKT2 PHOSPHORYLATION | Apr 16, 2017 | Abandoned |
Array
(
[id] => 14521667
[patent_doc_number] => 10338084
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-07-02
[patent_title] => Processing reagent and use thereof in assays for detection of analytes associated with a binding protein
[patent_app_type] => utility
[patent_app_number] => 15/482332
[patent_app_country] => US
[patent_app_date] => 2017-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 11
[patent_no_of_words] => 13679
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15482332
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/482332 | Processing reagent and use thereof in assays for detection of analytes associated with a binding protein | Apr 6, 2017 | Issued |
Array
(
[id] => 15073527
[patent_doc_number] => 10466244
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-11-05
[patent_title] => Methods and materials for identifying therapeutic response in chronic myeloid leukemia
[patent_app_type] => utility
[patent_app_number] => 15/481213
[patent_app_country] => US
[patent_app_date] => 2017-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 18
[patent_no_of_words] => 6079
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 166
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15481213
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/481213 | Methods and materials for identifying therapeutic response in chronic myeloid leukemia | Apr 5, 2017 | Issued |
Array
(
[id] => 12003452
[patent_doc_number] => 20170307607
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-26
[patent_title] => 'A METHOD FOR DIAGNOSING PRIMARY BILIARY CIRRHOSIS (PBC) USING NOVEL AUTOANTIGENS'
[patent_app_type] => utility
[patent_app_number] => 15/469350
[patent_app_country] => US
[patent_app_date] => 2017-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17290
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15469350
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/469350 | Method for diagnosing primary biliary cirrhosis (PBC) using novel autoantigens | Mar 23, 2017 | Issued |
Array
(
[id] => 11867581
[patent_doc_number] => 20170234865
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-17
[patent_title] => 'Methods, Compositions and Devices for Improving the Sensitivity of Assays'
[patent_app_type] => utility
[patent_app_number] => 15/433694
[patent_app_country] => US
[patent_app_date] => 2017-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6893
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15433694
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/433694 | Methods, Compositions and Devices for Improving the Sensitivity of Assays | Feb 14, 2017 | Abandoned |
Array
(
[id] => 11529950
[patent_doc_number] => 20170089928
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-30
[patent_title] => 'METHOD FOR DETECTION OF BASIC PEPTIDE AND REAGENT FOR DETECTION OF BASIC PEPTIDE'
[patent_app_type] => utility
[patent_app_number] => 15/380220
[patent_app_country] => US
[patent_app_date] => 2016-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 9420
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15380220
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/380220 | Method for detection of basic peptide and reagent for detection of basic peptide | Dec 14, 2016 | Issued |
Array
(
[id] => 14965539
[patent_doc_number] => 20190310248
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-10
[patent_title] => METHOD FOR REMOVING MICROORGANISM, CELL, TINY VESICLE SECRETED BY SAID MICROORGANISM OR SAID CELL OR VIRUS FROM CARRIER-IMMOBILIZED ANTIBODY
[patent_app_type] => utility
[patent_app_number] => 16/062509
[patent_app_country] => US
[patent_app_date] => 2016-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10458
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16062509
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/062509 | METHOD FOR REMOVING MICROORGANISM, CELL, TINY VESICLE SECRETED BY SAID MICROORGANISM OR SAID CELL OR VIRUS FROM CARRIER-IMMOBILIZED ANTIBODY | Dec 11, 2016 | Abandoned |
Array
(
[id] => 11972534
[patent_doc_number] => 20170276688
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-28
[patent_title] => 'ANTI-HIMF ANTIBODIES TO TREAT LUNG DISEASES'
[patent_app_type] => utility
[patent_app_number] => 15/372906
[patent_app_country] => US
[patent_app_date] => 2016-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 9165
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15372906
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/372906 | ANTI-HIMF ANTIBODIES TO TREAT LUNG DISEASES | Dec 7, 2016 | Abandoned |
Array
(
[id] => 15965545
[patent_doc_number] => 20200166524
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-28
[patent_title] => EXTRACELLULAR VESICLE MARKERS FOR STABLE ANGINA AND UNSTABLE ANGINA
[patent_app_type] => utility
[patent_app_number] => 16/060155
[patent_app_country] => US
[patent_app_date] => 2016-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20628
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 262
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16060155
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/060155 | EXTRACELLULAR VESICLE MARKERS FOR STABLE ANGINA AND UNSTABLE ANGINA | Dec 6, 2016 | Abandoned |
Array
(
[id] => 11964932
[patent_doc_number] => 20170269085
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-21
[patent_title] => 'LYSYL OXIDASE-LIKE 2 ASSAY AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/366986
[patent_app_country] => US
[patent_app_date] => 2016-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 28734
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15366986
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/366986 | LYSYL OXIDASE-LIKE 2 ASSAY AND METHODS OF USE THEREOF | Nov 30, 2016 | Abandoned |
Array
(
[id] => 13539421
[patent_doc_number] => 20180321257
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-08
[patent_title] => USE OF CD146 AS A MARKER OF THE VASCULAR WALL TENSION
[patent_app_type] => utility
[patent_app_number] => 15/770746
[patent_app_country] => US
[patent_app_date] => 2016-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11954
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15770746
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/770746 | USE OF CD146 AS A MARKER OF THE VASCULAR WALL TENSION | Nov 6, 2016 | Abandoned |
Array
(
[id] => 11500684
[patent_doc_number] => 20170074868
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-16
[patent_title] => 'METHODS AND COMPOSITIONS FOR THE EVALUATION OF RENAL INJURY USING HYALURONIC ACID'
[patent_app_type] => utility
[patent_app_number] => 15/345255
[patent_app_country] => US
[patent_app_date] => 2016-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 24738
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15345255
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/345255 | METHODS AND COMPOSITIONS FOR THE EVALUATION OF RENAL INJURY USING HYALURONIC ACID | Nov 6, 2016 | Abandoned |
Array
(
[id] => 17714588
[patent_doc_number] => 11378577
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-07-05
[patent_title] => Reagent and method for measuring thrombin-antithrombin complex
[patent_app_type] => utility
[patent_app_number] => 15/772037
[patent_app_country] => US
[patent_app_date] => 2016-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 9
[patent_no_of_words] => 8982
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 224
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15772037
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/772037 | Reagent and method for measuring thrombin-antithrombin complex | Oct 30, 2016 | Issued |
Array
(
[id] => 11569868
[patent_doc_number] => 20170108512
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-20
[patent_title] => 'USE OF BIOMARKERS FOR DETECTION OF EXCESSIVE ALCOHOL USE'
[patent_app_type] => utility
[patent_app_number] => 15/285828
[patent_app_country] => US
[patent_app_date] => 2016-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 10269
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15285828
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/285828 | USE OF BIOMARKERS FOR DETECTION OF EXCESSIVE ALCOHOL USE | Oct 4, 2016 | Abandoned |
Array
(
[id] => 15980583
[patent_doc_number] => 10670612
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-02
[patent_title] => Immunoassay standards and measurement of clinical biomarkers using intra-assay calibration standards
[patent_app_type] => utility
[patent_app_number] => 15/285750
[patent_app_country] => US
[patent_app_date] => 2016-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 36
[patent_no_of_words] => 11829
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15285750
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/285750 | Immunoassay standards and measurement of clinical biomarkers using intra-assay calibration standards | Oct 4, 2016 | Issued |
Array
(
[id] => 14537423
[patent_doc_number] => 20190204333
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-04
[patent_title] => METHOD OF TREATMENT AND PROGNOSIS
[patent_app_type] => utility
[patent_app_number] => 15/764531
[patent_app_country] => US
[patent_app_date] => 2016-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14842
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15764531
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/764531 | METHOD OF TREATMENT AND PROGNOSIS | Sep 27, 2016 | Abandoned |
Array
(
[id] => 11529935
[patent_doc_number] => 20170089914
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-30
[patent_title] => 'ANTI-PEMBROLIZUMAB ANTIBODIES'
[patent_app_type] => utility
[patent_app_number] => 15/274330
[patent_app_country] => US
[patent_app_date] => 2016-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 18337
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15274330
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/274330 | Anti-pembrolizumab antibodies | Sep 22, 2016 | Issued |
Array
(
[id] => 11896319
[patent_doc_number] => 09766250
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-09-19
[patent_title] => 'Method for detecting protein-protein interaction'
[patent_app_type] => utility
[patent_app_number] => 15/273815
[patent_app_country] => US
[patent_app_date] => 2016-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 42
[patent_figures_cnt] => 49
[patent_no_of_words] => 33967
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 319
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15273815
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/273815 | Method for detecting protein-protein interaction | Sep 22, 2016 | Issued |
Array
(
[id] => 13156151
[patent_doc_number] => 10094793
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-10-09
[patent_title] => Nanomaterial-based photothermal immunosensing for quantitative detection of disease biomarkers
[patent_app_type] => utility
[patent_app_number] => 15/269301
[patent_app_country] => US
[patent_app_date] => 2016-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 15
[patent_no_of_words] => 11238
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 151
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15269301
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/269301 | Nanomaterial-based photothermal immunosensing for quantitative detection of disease biomarkers | Sep 18, 2016 | Issued |